Cambridge Trust Co. Sells 141 Shares of Kimberly-Clark Co. (NYSE:KMB)

Cambridge Trust Co. trimmed its stake in Kimberly-Clark Co. (NYSE:KMB) by 2.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,887 shares of the company’s stock after selling 141 shares during the period. Cambridge Trust Co.’s holdings in Kimberly-Clark were worth $761,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Pathway Financial Advisers LLC bought a new position in shares of Kimberly-Clark in the first quarter worth approximately $67,000. Cetera Advisors LLC boosted its stake in Kimberly-Clark by 422.1% in the first quarter. Cetera Advisors LLC now owns 77,837 shares of the company’s stock worth $10,068,000 after buying an additional 62,929 shares in the last quarter. Cetera Investment Advisers grew its holdings in shares of Kimberly-Clark by 207.7% in the first quarter. Cetera Investment Advisers now owns 208,989 shares of the company’s stock worth $27,033,000 after purchasing an additional 141,073 shares during the last quarter. Atria Investments Inc grew its holdings in shares of Kimberly-Clark by 18.4% in the first quarter. Atria Investments Inc now owns 24,924 shares of the company’s stock worth $3,224,000 after purchasing an additional 3,876 shares during the last quarter. Finally, Swedbank AB bought a new position in shares of Kimberly-Clark in the first quarter worth approximately $20,659,000. 76.29% of the stock is currently owned by institutional investors.

Kimberly-Clark Stock Up 1.2 %

Shares of KMB traded up $1.62 during midday trading on Friday, reaching $140.10. 2,401,756 shares of the stock were exchanged, compared to its average volume of 2,480,943. Kimberly-Clark Co. has a 52 week low of $116.32 and a 52 week high of $145.62. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59. The company’s 50 day moving average is $138.33 and its two-hundred day moving average is $130.68. The company has a market capitalization of $47.19 billion, a P/E ratio of 25.75, a PEG ratio of 2.95 and a beta of 0.37.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $1.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.25. Kimberly-Clark had a return on equity of 223.55% and a net margin of 11.28%. The business had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $5.10 billion. During the same quarter in the prior year, the company earned $1.65 EPS. The business’s revenue was down 2.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Kimberly-Clark Co. will post 7.21 earnings per share for the current year.

Kimberly-Clark Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 2nd. Investors of record on Friday, September 6th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.48%. The ex-dividend date of this dividend is Friday, September 6th. Kimberly-Clark’s payout ratio is currently 89.71%.

Analyst Upgrades and Downgrades

KMB has been the subject of several recent research reports. The Goldman Sachs Group raised their price objective on Kimberly-Clark from $135.00 to $152.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Citigroup raised their price objective on Kimberly-Clark from $111.00 to $125.00 and gave the company a “sell” rating in a research report on Wednesday, April 24th. Bank of America raised Kimberly-Clark from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $115.00 to $160.00 in a research report on Thursday, June 13th. Wells Fargo & Company lowered their price target on Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. Finally, TD Cowen started coverage on Kimberly-Clark in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Kimberly-Clark has an average rating of “Hold” and a consensus target price of $145.67.

Insider Activity at Kimberly-Clark

In related news, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the sale, the insider now owns 7,377 shares of the company’s stock, valued at $1,038,976.68. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares in the company, valued at $1,038,976.68. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $141.42, for a total value of $5,331,392.58. Following the completion of the transaction, the insider now owns 19,935 shares of the company’s stock, valued at $2,819,207.70. The disclosure for this sale can be found here. Insiders have sold a total of 43,312 shares of company stock valued at $6,106,519 over the last quarter. 0.62% of the stock is owned by corporate insiders.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.